Economic evaluation: An introduction

BMJ

Volumn 316, Issue 7136, 1998, Pages 1013-

  Raftery, James ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; COST BENEFIT ANALYSIS; ECONOMICS; NATIONAL HEALTH SERVICE; QUALITY ADJUSTED LIFE YEAR; REVIEW; UNITED KINGDOM; UNITED STATES; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE QUALITY; MEDICAL DECISION MAKING; PRIORITY JOURNAL; SHORT SURVEY;

COST-BENEFIT ANALYSIS; GREAT BRITAIN; QUALITY-ADJUSTED LIFE YEARS; STATE MEDICINE; TECHNOLOGY ASSESSMENT, BIOMEDICAL; UNITED STATES;

EID: 0032574397     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.316.7136.1013     Document Type: Article

References (8)

1. Commonwealth of Australia.Guidelines to the pharmaceutical industry on the preparation of submissions to the Pharmaceutical Benefits Advisory Committee: including submissions involving economic analysis Canberra: Department of Health, Housing, and Community Services,1992.
2. Tengs TO.An evaluation of Oregon's Medicaid rationing algorithms, Health Economics 1996;5:171–81.
3. Drummond MF.Economic analysis alongside controlled trials. Leeds: N.H. Executive, 1994.
4. Gold M.R. Siegel JE.Ed. Russell L.B. Weinstein MC. Cost effectiveness in health and medicine. New York: OUP, 1996.
5. Culyer A. The normative economics of healthcare finance and provision. In: Ed. McGuire A. Fenn P. Mayhew K eds. Providing healthcare: the economics of alternative systems of finance and delivery. Oxford: OUP, 1991.
6. Drummond M.F. Jefferson TO on behalf of BMJ Economic Evaluation Working Party.Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 1996;313:275–83.
7. Sheldon T.Problems of modelling in the economic evaluation of health care. Health Economics 1996;5:1–11.
8. Hutton J.Economic evaluation of healthcare: a half way technology. Health Economics 1994;3:1–4.